CION Cancer Clinics
Needle tract seeding: the biopsy risk people worry about | CION Cancer Clinics
A liver biopsy can, uncommonly, leave a few cancer cells along the needle's path. Most people who have one never face this, and good technique lowers the risk further. This page explains what seeding is, why it matters more in primary liver cancer, how teams decide whether you need a biopsy at all, and what to ask before one is booked. At CION Cancer Clinics, our team goes through your scan, blood test and biopsy reports with you and plans the next step.
On this page
- Can a liver biopsy spread cancer along the needle?
- What makes seeding more or less likely?
- How does a team decide whether you need a biopsy at all?
- What do the biopsy words on your report mean?
- Does touching a tumour with a needle make cancer spread?
- What this page cannot tell you
- Common questions about needle tract seeding
The short answer
Can a liver biopsy spread cancer along the needle?
Yes, it can happen, but it is uncommon. Needle tract seeding means a few cancer cells are carried out of a liver tumour along the path the biopsy needle took, and later grow into a small nodule in the liver tissue, the muscle of the belly wall or the skin. Most people who have a liver biopsy never have this problem.
Why it is talked about more in liver cancer
For most cancers, a biopsy is simply the next step and nobody weighs it twice. Liver cancer is different. Hepatocellular carcinoma (HCC, the common cancer that starts in the liver cells) can often be diagnosed from a good-quality scan alone, without any needle at all. Because a biopsy is frequently optional, its small risks, including seeding and bleeding, are weighed more carefully. That is why your doctor may bring the topic up, or why you may have read about it late at night.
Who this page is for
This page is about biopsies of a suspected primary liver tumour. If your report says the liver spots are secondary, meaning cancer that spread from the bowel, breast or elsewhere, the reasoning is different and is explained on our page about primary and secondary liver cancer.
Seeding is a real but small risk. It is one reason a biopsy is chosen carefully, not a reason to refuse one you need.What changes the risk
What makes seeding more or less likely?
The risk is not the same for everyone. A few practical things shape it, and your team looks at each one before deciding.
Where the tumour sits
A tumour right under the liver surface, with no normal liver between it and the skin, gives cells an easier path out. Radiologists prefer a route that passes through a layer of healthy liver first, which tends to hold back stray cells.
The type of needle and approach
Many centres use a coaxial technique: one outer guide needle stays in place while samples are taken through it. The tumour is reached once, and fewer passes are made through the tissue.
How many passes are made
Each extra pass is another chance for cells to be dragged along. A skilled operator aims to get enough tissue in as few passes as possible, which also lowers the bleeding risk.
What happens next in treatment
If you are likely to have surgery or a transplant that aims to remove every cancer cell, a seeded nodule outside the liver matters more. This is why transplant and surgical teams are often the most cautious about biopsy.
Matters most when
- The plan is a transplant or a resection with curative intent
- The scan already gives a confident answer
- The tumour lies at the liver edge
Not sure whether this applies to you?
Ask an oncologistHow the decision is made
How does a team decide whether you need a biopsy at all?
The scan is read first
A triple-phase CT or MRI with contrast is reviewed. If the tumour shows the classic HCC pattern in a liver at risk, the report may call it LR-5 on the LI-RADS scale, which is enough to diagnose without a needle.
The tumour board weighs the doubt
If the picture is not typical, or the liver has no cirrhosis, or another cancer could explain the spot, a biopsy usually becomes necessary. At CION, the tumour board reviews the scans before this call is made.
The route is planned
When a biopsy is chosen, the radiologist plans a path through healthy liver, with a guide needle and as few passes as possible. CION arranges this through accredited partner hospitals.
The tissue answers several questions
A good sample confirms the diagnosis, the cancer type and sometimes the molecular features that guide drug choice. The practical side is covered on our page on what to expect on the day of a liver biopsy.
On your report
What do the biopsy words on your report mean?
- Needle tract seeding
- Cancer cells left along the path of a biopsy or treatment needle, which later grow into a small lump outside the tumour.
- Core biopsy
- A thin cylinder of tissue taken with a hollow needle. It shows how the cells are arranged, which matters for diagnosis.
- Fine needle aspiration (FNA)
- A thinner needle that draws out loose cells. It gives less information than a core and is used less often for the liver.
- Coaxial technique
- An outer guide needle stays in place while samples are taken through it, so the tumour is entered once.
- Subcapsular
- Lying just under the thin outer covering of the liver, with little or no healthy liver in front of it.
- LR-5
- The LI-RADS category meaning the scan shows definite HCC. In most people at risk, no biopsy is needed to confirm it.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Does touching a tumour with a needle make cancer spread?
Seeding is a local event along one needle path. A biopsy does not send cancer into the blood or make it race to the lungs or bones. That spread, when it happens, is driven by the cancer itself.
For HCC, skipping the needle is often the more careful choice. International guidelines accept a confident scan in a liver at risk as a full diagnosis. Read more on why HCC can be diagnosed without a biopsy.
A seeded nodule is usually small and found on a follow-up scan or felt under the skin. It can often be treated on its own with surgery, ablation or radiation, depending on where it is.
When the scan is unclear, guessing the diagnosis is the bigger risk. Treating the wrong cancer, or treating something that was never cancer, causes more harm than a carefully planned biopsy.
Being straight with you
What this page cannot tell you
It cannot tell you whether you personally need a biopsy. That depends on how your scan looks, whether your liver has cirrhosis or hepatitis, whether you have had another cancer, and what treatment is being considered. Only a team that has seen your actual images can weigh those together.
Who this does not apply to
If the spots in your liver are thought to have spread from another cancer, a biopsy is often the quickest way to confirm where they came from, and seeding is rarely the deciding worry. The same is true for cholangiocarcinoma (cancer of the bile ducts inside the liver), where a biopsy is usually needed. Our page on when a liver biopsy is necessary covers these cases.
The evidence is not perfect
Studies of seeding are mostly older and used different needles and techniques from those common today. Figures vary widely between reports. What is consistent is that the risk is small and that technique matters. If you have a biopsy booked and you are worried, it is fair to ask the radiologist how they will approach it.
Bring your scan discs and reports to any appointment. A second look at the images often settles whether a biopsy is needed.Questions we are asked
Common questions about needle tract seeding
How common is needle tract seeding after a liver biopsy?
It is uncommon. Most people who have a liver biopsy never develop it. Reports vary because studies used different needles and methods, and newer techniques with a guide needle appear to lower the risk further. Your radiologist can explain how they plan to keep it low in your case.
How would I know if seeding had happened?
Most seeded nodules are found on a routine follow-up scan. Some are felt as a small, firm lump in the skin or belly wall near the old biopsy mark. If you notice a new lump there in the months after a biopsy, tell your oncologist so it can be checked.
Can a seeded nodule be treated?
Often, yes. Because it is usually small and in one place, it can be removed or treated locally, depending on where it sits. Treatment choice also depends on what is happening in the liver itself, so the tumour board looks at the whole picture together.
Does ablation or TACE carry the same risk?
Ablation uses a needle placed into the tumour, so a small seeding risk exists there too. Operators often heat the track as the needle is withdrawn to reduce it. TACE goes through a blood vessel in the groin or wrist, not through the tumour from outside, so seeding along a tract does not apply in the same way.
My doctor wants a biopsy. Should I refuse?
Not without a conversation first. Ask why the scan alone is not enough, what the biopsy will change, and how the route will be planned. If the answer is that the scan is unclear, a biopsy is usually the safer path. Our page on whether to insist on a biopsy covers the other side.
Does seeding stop me from having a transplant later?
It can complicate it, because a transplant aims to remove all the cancer, and cancer outside the liver usually rules a transplant out. This is one reason transplant teams often prefer a scan-based diagnosis. If transplant is a possibility, ask the transplant centre before any biopsy is booked.
Is a fine needle safer than a core biopsy?
A thinner needle is not automatically safer for seeding, and it gives less information, which can mean a repeat biopsy. Most teams prefer a core taken through a guide needle, so the tumour is entered once and enough tissue comes out the first time.
Who can look at my scans before I decide?
Your oncologist and a liver radiologist are the right people. CION can arrange a review of your scans by the tumour board, with a clear answer on whether a biopsy is needed. Call the helpline and keep your discs and reports ready.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Diagnosing Liver Cancer
- Cancer Research UK — Diagnosing liver cancer
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
- American College of Radiology — ACR Liver Imaging Reporting & Data System (LI-RADS®)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Not sure whether you really need a liver biopsy?
Send us your scans and reports, and the tumour board will tell you plainly whether a biopsy is needed and why. One helpline serves every CION centre.